DAX20.215 -0,5%ESt504.977 -0,8%Top 10 Crypto15,32 +3,9%Dow41.938 -1,6%Nas19.162 -1,6%Bitcoin92.015 -0,2%Euro1,0242 -0,6%Öl79,79 +3,4%Gold2.690 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Tesla A1CX3T Mercedes-Benz Group (ex Daimler) 710000 Rheinmetall 703000 Bayer BAY001 E.ON ENAG99 BASF BASF11 Take Two 914508 Volkswagen (VW) vz. 766403 Amazon 906866 Deutsche Telekom 555750 Siemens Energy ENER6Y Palantir A2QA4J Lufthansa 823212 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Arbeitsmarktdaten: DAX verabschiedet sich schwächer ins Wochenende -- Wall Street rot -- Tilray weitet Verluste aus -- Mercedes-Benz, D-Wave Quantum, SoundHound, Auric Minerals im Fokus
Top News
KW 2: So performanten die MDAX-Aktien in der vergangenen Woche KW 2: So performanten die MDAX-Aktien in der vergangenen Woche
Kryptowährungen in KW 2: Das hat sich bei Bitcoin, Ether & Co. in der vergangenen Woche getan Kryptowährungen in KW 2: Das hat sich bei Bitcoin, Ether & Co. in der vergangenen Woche getan
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Eli Lilly Aktie

NeuKaufenVerkaufen
Eli Lilly Aktien-Sparplan
775,10 EUR +5,70 EUR +0,74 %
STU
799,48 USD -0,26 USD -0,03 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.741,42 Mrd. EUR

KGV100,48Div. Rendite0,78%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
ZacksHere's Why Eli Lilly (LLY) Fell More Than Broader Market
Financial TimesNovo Nordisk, Eli Lilly and the GLP-1 economy
BenzingaEli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
MotleyFoolWhy Eli Lilly Was Such a Healthy Stock Today
EN, Eli LillyLilly appoints Thomas J. Fuchs as the company’s first chief AI officer
MotleyFoolWith Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
ZacksZacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
MotleyFoolBillion-Dollar News for Eli Lilly Stock Investors
ZacksEli Lilly (LLY) Rises But Trails Market: What Investors Should Know
BenzingaEvaluating Eli Lilly Against Peers In Pharmaceuticals Industry
ZacksEli Lilly to Invest $4.5B for New Manufacturing & Research Plant
BenzingaCracking The Code: Understanding Analyst Reviews For Eli Lilly
ZacksAre Medical Stocks Lagging Eli Lilly (LLY) This Year?
MotleyFoolThis IPO Biotech Stock Could Be the Next Eli Lilly
BenzingaEli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
BenzingaEli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
Business TimesEli Lilly shells out US$4.5 billion for new drug development plant
EN, Eli LillyLilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
PR NewswireLilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
BenzingaEli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Financial TimesCan Eli Lilly become the first $1tn drugmaker?
BenzingaEli Lilly Eyes New Trials For Weight-Loss Drugs In Non-Obese Patients
BenzingaEli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight
Financial TimesEli Lilly considers testing weight-loss drugs on people who are not overweight
BenzingaTradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points
ZacksIs Trending Stock Eli Lilly and Company (LLY) a Buy Now?
MotleyFoolSuccess in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
MotleyFoolPrediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
ZacksEli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors
BenzingaEli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
BenzingaEli Lilly Unusual Options Activity
ZacksEli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
BenzingaEli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
PR NewswireNew data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis
EN, Eli LillyNew data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis
Benzinga$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
EN, Eli LillyLilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease
PR NewswireLilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease
BenzingaSpotlight on Eli Lilly: Analyzing the Surge in Options Activity
MotleyFoolPrediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
Wer­bung

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.